Diagnosed with androgen-independent prostate cancer in 2003, Ken
Gannon has tried several different medications and enrolled in
multiple clinical trials in the hope of keeping the disease in
check- -and helping others.
To continue reading this article, you must login
Subscribe to Harvard Health Online for immediate access to health news and information from Harvard Medical School.